Speaker
Martin Mendoza, PhD
CHIEF HEALTH EQUITY OFFICER AND DIRECTOR OF THE OFFICE OF MINORITY HEALTH, CENTERS FOR MEDICARE AND MEDICAID SERVICES
Martin Mendoza, Ph.D., serves as the Chief Health Equity Officer at the Centers for Medicare and Medicaid Services (CMS) and Director of the CMS Office of Minority Health (OMH). In this role, Dr. Mendoza leads OMH in its mission towards the advancement and integration of health equity in the development, evaluation, and implementation of CMS’s policies, programs, and partnerships.
Prior to CMS, Dr. Mendoza served as the first Director of Health Equity for the National Institutes of Health's (NIH) All of Us Research Program where he provided leadership and high-level expertise to improve inclusion and equity in precision medicine.
Before joining All of Us, Dr. Mendoza led extramural research for minority health in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). He is a recognized expert in clinical trial diversity and has testified on it before Congress. He is also the primary author of the pivotal FDA guidance recommending that clinical trial sponsors submit a diversity action plan to FDA. Dr. Mendoza’s original idea and recommendation became federal public law in December 2022.
Dr. Mendoza has also served as director of the Division of Policy and Data in the Office of Minority Health in the U.S. Department of Health and Human Services Office of the Secretary, as well as in multiple NIH Institutes including the National Institute of Neurological Disorders and Stroke, the National Cancer Institute, and the National Human Genome Research Institute where he assisted in the genetic mapping of the Human Genome Project.
Dr. Mendoza is a graduate of the University of Maryland, Baltimore County, and received his Ph.D. in cancer biology from Johns Hopkins University.
Prior to CMS, Dr. Mendoza served as the first Director of Health Equity for the National Institutes of Health's (NIH) All of Us Research Program where he provided leadership and high-level expertise to improve inclusion and equity in precision medicine.
Before joining All of Us, Dr. Mendoza led extramural research for minority health in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). He is a recognized expert in clinical trial diversity and has testified on it before Congress. He is also the primary author of the pivotal FDA guidance recommending that clinical trial sponsors submit a diversity action plan to FDA. Dr. Mendoza’s original idea and recommendation became federal public law in December 2022.
Dr. Mendoza has also served as director of the Division of Policy and Data in the Office of Minority Health in the U.S. Department of Health and Human Services Office of the Secretary, as well as in multiple NIH Institutes including the National Institute of Neurological Disorders and Stroke, the National Cancer Institute, and the National Human Genome Research Institute where he assisted in the genetic mapping of the Human Genome Project.
Dr. Mendoza is a graduate of the University of Maryland, Baltimore County, and received his Ph.D. in cancer biology from Johns Hopkins University.
Speaking In
9:10 AM - 9:30 AM
Tuesday, November 19